2 completed, 2 terminated, 2 unknown. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Completed 2, Terminated 2, Unknown 2 |
Follow SARS-CoV2 Infection: new trials by email Literature Review of SARS-CoV2 Infection trials Research Report on SARS-CoV2 Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fourth Dose of mRNA COVID-19 Vaccine in Residents of LTCFs mRNA- COVID-19, Prevnar13 - SARS-CoV2 Infection, Coronavirus Infection | Phase 4 | Unknown | Mark Loeb | 414 | 2022-08-01 | 2022-06-30 |
| Echinaforce COVID-19 Shedding Study Echinaforce Forte tablets, Echinaforce Chewable tablets, Echinaforce tincture - COVID-19 Respiratory Infection, SARS-CoV2 Infection | Phase 4 | Terminated | A. Vogel AG | 40 | 2021-11-15 | 2024-08-06 |
| RECOVAC Repeated Vaccination Study mRNA-1273, Ad26.COV2.S vaccine - Covid19, Kidney Diseases | Phase 4 | Completed | University Medical Center Groningen | 336 | 2021-10-21 | 2022-03-29 |
| SARS-CoV-2 Immune Responses After COVID-19 Therapy and Subsequent Vaccine Study-provided Moderna mRNA-1273 COVID-19 vaccine, Community-provided Moderna mRNA-1273 COVID-19 Vaccine, Community-Provided Pfizer-BioNTech BNT162b2 COVID-19 Vaccine - Covid19, SARS-CoV2 Infection | Phase 4 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 43 | 2021-07-09 | 2023-05-24 |
| Treatment of Nosocomial COVID-19 Anti-SARS-CoV-2 mAb - Covid19, Nosocomial Infection | Phase 4 | Terminated | University of Calgary | 46 | 2021-02-12 | 2023-04-19 |
| Ivermectin vs Combined Hydroxychloroquine and Antiretroviral Drugs (ART) Among Asymptomatic COVID-19 Infection Ivermectin Pill, Combined ART/hydroxychloroquine - Asymptomatic Infections, SARS-CoV2 Infection | Phase 4 | Unknown | Mahidol University | 80 | 2020-07-13 | 2021-01-11 |
COVID-19 (6) · Asymptomatic Infections (1) · Coronavirus Infections (1) · Cross Infection (1) · Kidney Diseases (1)
Coronaviridae Infections (6) · Infections (6) · Lung Diseases (6) · Nidovirales Infections (6) · Pneumonia (6) · Pneumonia, Viral (6) · RNA Virus Infections (6) · Respiratory Tract Diseases (6) · Respiratory Tract Infections (6) · Virus Diseases (6) · Coronavirus Infections (5) · Disease Attributes (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Asymptomatic Diseases (1)
2019-nCoV Vaccine mRNA-1273 (2) · Ad26COVS1 (1) · Ivermectin (1) · Pneumococcal Vaccines (1) · bamlanivimab (1) · casirivimab (1) · sotrovimab (1)
A. Vogel AG (1) · Mahidol University (1) · Mark Loeb (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · University Medical Center Groningen (1) · University of Calgary (1)
Canada (2) · Bulgaria (1) · Netherlands (1) · Thailand (1) · United States (1)
Alain Tremblay (1) · David Smith, MD, MAS (1) · Jan-Stephan F Sanders, MD PhD (1) · Mark Loeb, MD (1) · Robert Fowler (1) · Srinivas Murthy (1) · Yupin Suputtamongkol, MD (1)
PMID 34473343, PMID 36354032, PMID 38902860, PMID 39272117, PMID 41700320